We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$115B
AUM Growth
+$6.24B
Cap. Flow
+$1B
Cap. Flow %
0.87%
Top 10 Hldgs %
23.71%
Holding
4,165
New
247
Increased
1,898
Reduced
1,581
Closed
296

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Healthcare 8.69%
3 Financials 8.53%
4 Industrials 6.69%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGB
2501
Blackstone Strategic Credit 2027 Term Fund
BGB
$504M
$918K ﹤0.01%
86,209
+11,511
+15% +$126K
OEFA
2502
ALPS O'Shares International Developed Quality Dividend ETF
OEFA
$37.5M
$915K ﹤0.01%
34,045
+173
+0.5% +$4.42K
KOP icon
2503
Koppers
KOP
$886M
$915K ﹤0.01%
26,177
+89
+0.3% +$2.96K
EPRF icon
2504
Innovator S&P Investment Grade Preferred ETF
EPRF
$68.6M
$914K ﹤0.01%
49,212
+306
+0.6% +$5.88K
FPL
2505
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$914K ﹤0.01%
152,792
-12,791
-8% -$78.4K
JOET icon
2506
Virtus Terranova US Quality Momentum ETF
JOET
$253M
$913K ﹤0.01%
+33,192
New +$909K
JPIB icon
2507
JPMorgan International Bond Opportunities ETF
JPIB
$2.13B
$912K ﹤0.01%
19,260
NVO
2508
CALL
Novo Nordisk
NVO
$202B
$910K ﹤0.01%
+13,000
New +$922K
SILV
2509
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$908K ﹤0.01%
127,209
+39,652
+45% +$243K
PACB icon
2510
Pacific Biosciences
PACB
$361M
$908K ﹤0.01%
78,382
-7,078
-8% -$70.4K
TOST icon
2511
Toast
TOST
$20.2B
$905K ﹤0.01%
51,011
+36,122
+243% +$712K
NATH icon
2512
Nathan's Famous
NATH
$397M
$905K ﹤0.01%
11,974
-68
-0.6% -$5.03K
FR icon
2513
First Industrial Realty Trust
FR
$8.36B
$904K ﹤0.01%
16,990
+7,287
+75% +$380K
PDX
2514
PIMCO Dynamic Income Strategy Fund
PDX
$979M
$901K ﹤0.01%
61,740
-1,002
-2% -$15.2K
JMUB icon
2515
JPMorgan Municipal ETF
JMUB
$8.51B
$900K ﹤0.01%
17,770
-3,378
-16% -$170K
NUBD icon
2516
Nuveen ESG US Aggregate Bond ETF
NUBD
$464M
$899K ﹤0.01%
40,207
+5,905
+17% +$131K
GLP icon
2517
Global Partners
GLP
$1.71B
$893K ﹤0.01%
28,777
+17,207
+149% +$581K
PBF icon
2518
PBF Energy
PBF
$8.53B
$889K ﹤0.01%
20,512
-19,688
-49% -$829K
DYN icon
2519
Dyne Therapeutics
DYN
$4.8B
$889K ﹤0.01%
77,203
+21,836
+39% +$284K
USPH icon
2520
US Physical Therapy
USPH
$1.2B
$889K ﹤0.01%
9,076
+2,358
+35% +$225K
UFCS icon
2521
United Fire Group
UFCS
$1.38B
$887K ﹤0.01%
33,402
-32
-0.1% -$911
NE icon
2522
Noble Corp
NE
$7.22B
$886K ﹤0.01%
+22,442
New +$898K
REET icon
2523
iShares Global REIT ETF
REET
$5.09B
$885K ﹤0.01%
38,593
-7,275
-16% -$172K
OSIS icon
2524
OSI Systems
OSIS
$3.79B
$884K ﹤0.01%
8,634
+1,506
+21% +$139K
AMPH icon
2525
Amphastar Pharmaceuticals
AMPH
$889M
$884K ﹤0.01%
23,561
+483
+2% +$15.8K

Similar funds

Raymond James & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Raymond James & Associates held 4,165 positions worth $115B, up 5.7% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2023 filing shows 247 new, 1,898 increased, 1,581 reduced and 296 closed positions. Its largest new stake was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2023 buy was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2023, an estimated $413M increase.
  • Raymond James & Associates's biggest Q1 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $18.8M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $115B portfolio in Q1 2023.
  • Raymond James & Associates opened 247 new positions and closed 296 in Q1 2023.
  • Raymond James & Associates's portfolio value rose 5.7% quarter-over-quarter to $115B.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.